Document Detail

Gluten sensitivity presenting as a neuropsychiatric disorder.
Jump to Full Text
MedLine Citation:
PMID:  24693281     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
There has been increasing recognition in the medical community and the general public of the widespread prevalence of gluten sensitivity. Celiac disease (CD) was initially believed to be the sole source of this phenomenon. Signs and symptoms indicative of nonceliac gluten sensitivity (NCGS), in which classical serum and intestinal findings of CD may be absent, have been frequently reported of late. Clinical manifestations in patients with NCGS are characteristically triggered by gluten and are ameliorated or resolved within days to weeks of commencing a gluten-free diet. Emerging scientific literature contains several reports linking gluten sensitivity states with neuropsychiatric manifestations including autism, schizophrenia, and ataxia. A clinical review of gluten sensitivity is presented alongside a case illustrating the life-changing difference achieved by gluten elimination in a patient with a longstanding history of auditory and visual hallucinations. Physicians in clinical practice should routinely consider sensitivity issues as an etiological determinant of otherwise inexplicable symptoms. Pathophysiologic mechanisms to explain the multisystem symptomatology with gluten sensitivity are considered.
Authors:
Stephen J Genuis; Rebecca A Lobo
Publication Detail:
Type:  Journal Article; Review     Date:  2014-02-12
Journal Detail:
Title:  Gastroenterology research and practice     Volume:  2014     ISSN:  1687-6121     ISO Abbreviation:  Gastroenterol Res Pract     Publication Date:  2014  
Date Detail:
Created Date:  2014-04-02     Completed Date:  2014-06-24     Revised Date:  2014-06-24    
Medline Journal Info:
Nlm Unique ID:  101475557     Medline TA:  Gastroenterol Res Pract     Country:  Egypt    
Other Details:
Languages:  eng     Pagination:  293206     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Gastroenterol Res Pract
Journal ID (iso-abbrev): Gastroenterol Res Pract
Journal ID (publisher-id): GRP
ISSN: 1687-6121
ISSN: 1687-630X
Publisher: Hindawi Publishing Corporation
Article Information
Download PDF
Copyright © 2014 S. J. Genuis and R. A. Lobo.
open-access:
Received Day: 20 Month: 10 Year: 2013
Revision Received Day: 25 Month: 12 Year: 2013
Accepted Day: 2 Month: 1 Year: 2014
Print publication date: Year: 2014
Electronic publication date: Day: 12 Month: 2 Year: 2014
Volume: 2014E-location ID: 293206
PubMed Id: 24693281
ID: 3944951
DOI: 10.1155/2014/293206

Gluten Sensitivity Presenting as a Neuropsychiatric Disorder
Stephen J. Genuis1*
Rebecca A. Lobo2
1Faculty of Medicine, University of Alberta, Edmonton, AB, Canada T6K 4C1
2Department of Family Medicine, University of Alberta, Edmonton, AB, Canada T6G 2C8
Correspondence: *Stephen J. Genuis: sgenuis@ualberta.ca
[other] Academic Editor: R. Eliakim

1. Introduction

Over the last decade, there have been increasing reports of myriad adverse reactions associated with gluten exposure. Classical manifestations of gluten intolerance are those of celiac disease (CD), including gastrointestinal upset, failure to thrive, weight loss, and anemia. However, emerging scientific literature has noted a link between gluten ingestion and symptomatology from nearly every organ system, often in the absence of classic histological findings of CD on intestinal biopsy.

It has been hypothesized for quite some time that gluten sensitivity may also impair central nervous system functioning [1]. In 1996, Hadjivassiliou et al. found a significant difference in the prevalence of patients with positive antigliadin antibodies amongst those with neurological symptoms of unknown cause (57%) compared to a control group of healthy patients (12%) [1]. Amid the 57% who did have positive antibody titres, the majority did not demonstrate histological evidence diagnostic of celiac disease. In a 2010 article published in Lancet Neurology, Hadjivassiliou and colleagues published additional support for the link between gluten sensitivity and neurological manifestations, including ataxia, neuropathy, encephalopathy, epilepsy, myopathy, and myelopathy [2]. Similar results continue to be reported in the medical literature and give credence to the association between gluten sensitivity and neurological symptoms in the absence of celiac disease [36].

In this paper, a clinical review of gluten sensitivity as it relates to mental health is presented for consideration as well as proposed pathophysiological mechanisms for the multimorbidity and neuropsychiatric symptoms associated with gluten sensitivity in some patients. A case history of a 23-year-old female with a longstanding history of auditory and visual hallucinations is initially presented as an example of what can be clinically achieved in gluten sensitive individuals following elimination of the inciting food trigger.


2. Case Report

From birth, the patient was described by her mother as a colicky but otherwise healthy infant. Around age 4 or 5, however, the child began to experience recurrent gastrointestinal problems, as well as the onset of frequent visual and auditory hallucinations. She recalls that she would often “see beings and, at times, entire scenes, that no one else would see.”

The nature of the hallucinations varied considerably. For example, her hallucinations ranged from explicit scenes of an 8-year-old, blonde haired boy named Tommy, who the patient believed to be a child her mother had miscarried, to ghosts and colorful fairies that communicated with her and slept in trees outside her window. These happy scenarios were sharply contrasted at times by terrifying hallucinations of hideous creatures covered in burns and boils who would threaten endless torture. Her hallucinations would sometimes be colored with religious themes and would solicit action on her part. For example, she recalls seeing beautiful, elaborate banquets in heaven with sparkling crystal goblets and hearing what she described as God's voice asking her to do specific, though seemingly random, tasks such as planting 3 plants in a particular part of the garden.

Some of her hallucinations were recurrent and many involved interaction. These experiences occurred on a nearly daily basis and were “just a part of (her) life.” Other than the visions of terror, she quite enjoyed her discussions with the majority of these unknown figures. The patient relates that these hallucinations were indistinguishable from reality, and at times she would physically reach out to touch the different characters without realizing they were not real.

The patient describes relying fairly heavily on these imaginary characters for companionship as a child and claims that they inhibited her ability to form friendships with other children. As she grew older, she also found these hallucinations quite distracting rendering her unable to concentrate adequately at school or to study for exams. After the patient disclosed these hallucinations to her mother, religious counsel was initially sought where it was suggested that the hallucinations were perhaps attributable to divine causes. Although the patient came from a loving and supportive family, these symptoms were never brought to medical attention.

The hallucinations as well as the gastrointestinal symptoms continued through her childhood and teen years, causing her to miss considerable amounts of school. After disclosing her abdominal symptoms, she was diagnosed by a physician with irritable bowel syndrome and was started on a daily regimen of high dose psyllium. On her own initiative, she began to experiment with elimination diets. She progressively eliminated soy, corn, and dairy but reported no change in any of her symptoms.

She began university and states it was a “miracle (she) never failed out of school” and maintained a C average. While at university, she met a young man and entered a romantic relationship with him. Although quite smitten, she reports that relapsing hallucinations took a toll on their relationship as she was, at times, affected to the point of not recognizing her boyfriend.

2.1. Dietary Manipulation

After attending nutrition lectures with her partner, the patient was introduced to the idea of gluten sensitivity and decided to abstain from gluten exposure. After eliminating gluten in September 2009, her gastrointestinal symptoms and hallucinations completely abated, and she felt an improvement in her ability to concentrate at school. She describes being able to sit down with sustained focus on study for the first time in her life, leading to the completion of her biology degree and the obtainment of employment.

Given the dramatic resolution of her symptoms, the patient chose to subsequently continue to remain entirely gluten-free. Despite her efforts, however, she occasionally experienced inadvertent gluten exposures, which triggered a clear reproduction of her previous symptoms including vivid hallucinations and severe abdominal pain. Exposure to gluten in each case involved traces contained in contaminated food rather than a willful transgression with copious ingestion of gluten. During these episodes she was sometimes with her partner, who noted she became completely disoriented and did not recognize familiar surroundings. For example, 3 hours after unintentionally eating gluten-containing oatmeal, she began to see “aliens” in the computer screens at work and believed they had restrained a teddy bear in some of the computer cords. She unplugged many of the apparatuses in the office in an attempt to rescue the stuffed animal. When her partner arrived to pick her up from work, she did not recognize him at all and was very confused about how he had a key to her apartment. The symptoms began to abate after 24 hours and completely resolved within 2-3 days.

The patient reports that this pattern was predictable. When reexposed to gluten, relapse consistently occurred within 3–5 hours and would result in significant disorientation and departure from reality. The episodes spontaneously resolved within 48–72 hours as long as she maintained a gluten-free diet. Once she was well again, she would accurately recall the details of the prior images and again attempt to remain gluten-free. Since May 2012, she has had no further exposure to gluten and has remained symptom-free with no GI or CNS complaints.

Although her ATTG (antitissue transglutaminase) antibodies on a regular diet containing gluten were negative, she did not have testing for antigliadin antibodies, IgE antibodies directed against wheat proteins, anti-endomysial antibodies (EMA), or anddeamidatedgliadin, and she did not have an open or double-blind placebo-controlled challenge. An intestinal biopsy was also not performed. From an investigation perspective, the patient declined to have a complete workup for celiac disease, feeling that she was well as long as she maintained a gluten-free diet and that there was no further need for investigations.


3. Search Strategy and Selection Criteria

PubMed was searched with no date restrictions using the following terms to identify relevant literature: hallucinations, celiac, gluten sensitivity, and nonceliac gluten sensitivity. As expected in this emerging field of research, the majority of results were case reports, observational studies and clinical reviews.


4. Discussion

There have been multiple reports linking celiac disease and/or gluten sensitivity with mental health manifestations including isolated psychosis and full blown schizophrenia [710]. As in our case history, these cases report complete symptom resolution with removal of gluten. There is also evidence of frequent gluten sensitivity (but not celiac disease) in schizophrenic patients [4]. Furthermore, similar reports are published dealing with various other neurological manifestations in response to gluten exposure including “idiopathic” ataxia and neuropathies [11], epilepsy [12], mood swings [6], and autism [13]. In addition to neuropsychiatric phenomena, there are reports of other organ system involvement including reversible cardiomyopathy [14], resolved primary infertility [15], uveitis [16], and osteoporosis [17] in relation to the gluten exposure in celiac disease.

4.1. Diagnostic Criteria

In the recent literature, there has been a distinction drawn between those with CD and those with nonceliac gluten sensitivity (NCGS) [1821]. The former denotes patients who typically have positive antibody titres and classic histological findings on intestinal biopsy, including crypt hyperplasia, villous atrophy, and an increase in intraepithelial lymphocytes [11]. NCGS, on the other hand, can be more difficult to diagnose. Although a group led by Gibson et al. in Australia first published a double-blind, randomized study confirming the reality of NCGS as a bona-fide medical condition [22], diagnostic criteria continue to be debated as the diagnosis is essentially determined as a result of self-reporting by patients. In general, these individuals have normal intestinal biopsies; they predictably react to gluten and have variable results with ATTG, anti-gliadin, and anti-EMA titres [2, 18, 19, 23]. Select private laboratories offer non-traditional stool testing to assess for antibodies and malabsorption secondary to gluten sensitivity; however, these tests have yet to be incorporated into formal diagnostic criteria and remain a controversial area requiring further investigation [24]. In fact, European studies to date studying stool antibody tests have demonstrated negative results [25].

NCGS patients demonstrate symptom improvement or resolution on a gluten-free diet and relapse with gluten challenge. Sapone et al. recently proposed an algorithm to differentiate between CD and NCGS. They suggest a diagnosis of NCGS can be made when symptoms are suggestive of CD, antibody titres are negative, and patients are symptomatic with gluten challenge, but this has yet to be widely accepted in the medical community and, unlike the description of other authors, requires all serology to be negative [23].

4.2. Acceptance by Health Care Professionals

There has been a tendency by some to attribute NCGS to placebo effect or somatization, particularly as the diagnosis is based on subjective self-reporting by patients. As well as the initial study confirming NCGS by Gibson et al. [22], however, an interesting study was recently published where groups of patients with CD, NCGS and a control group underwent complete psychiatric assessment and a subsequent gluten challenge [26]. There was found to be no difference between groups in their tendency to somatization, personality traits, or anxiety and depression symptoms. Moreover, patients with NCGS reported more symptoms than CD patients when challenged with gluten, suggesting NCGS to be a credible physical diagnosis [26].

As the evidence continues to accumulate, there does appear to be an increasing acceptance of this disease entity. A 2012 poll of nearly 1000 medical professionals reported that greater than 60% accepted the existence of NCGS and a follow-up article encouraged physicians to diagnose NCGS in patients who reacted to gluten and in whom celiac disease and wheat allergy had been excluded [27, 28]. A recent study, however, has suggested that NCGS may be more complex than previously realized. This study showed that after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates or FODMAPS (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols), most participants were unable to detect gluten-specific effects [29]. The findings suggest that NCGS may not always be an isolated condition and may involve interaction, potentiation, or overlap with other types of sensitivities.

4.3. Causative Pathophysiological Mechanisms

It is often thought that gluten induces systemic effects through inflammation of the intestinal tract. This is believed to cause malabsorption of various nutrients, leading to systemic deficiencies. For example, in the case of psychiatric illness, it is thought that there is perhaps impaired absorption of tryptophan, a precursor to serotonin, leading to serotonin deficiency and the presentation of mental illness [7] (see Figure 1). This explanation, however, is insufficient, given that not all patients reacting to gluten demonstrate intestinal changes and/or malabsorptive syndromes [3, 8, 26].

There have been numerous other theories proposed, which implicate specific antibodies, food allergies, and/or genetics in the pathophysiology of gluten-induced disease states [2, 3035]. These mechanisms are primarily disease and/or system-specific and thus fail to provide an explanation of how gluten ingestion can lead to symptoms in multiple organ systems. Moreover, not all patients claiming to be sensitive to gluten have any family history or known genetic predisposition to celiac disease. To date, these theories remain primarily speculative and further research is required to delineate their plausibility.

An alternative, and perhaps more likely explanation, is that of sensitivity-related illness (SRI) (Figure 2) [36]. This mechanism of disease has recently been described and discussed in the scientific literature [3642], whereby accumulated toxic insults often resulting from adverse chemical exposures lead to hypersensitivity and impaired tolerance of the immune system (known as toxicant induced loss of tolerance or “TILT”). With growing attention in the medical literature to the escalating problem of toxicant exposure and bioaccumulation within contemporary society [4345], this mechanism of illness has become compelling indeed. Notable groups such as the World Health Organization and the Centers for Disease Control have recently drawn attention to the reality of ubiquitous toxicant exposures and the chemical erosion of human health associated with toxicant accrual within the human body [4345].

After the bioaccumulation of a toxicant burden and the consequent immune dysregulation [36], seemingly insignificant environmental triggers can lead to the release of proinflammatory cytokines [46], antibodies, chemokines, and interleukins and produce a variety of symptoms, including neuropsychiatric issues, in the affected patient [36, 40, 47, 48]. Gluten is one such common trigger, and is hypothesized to be the culprit in the above case report. With the ability of SRI to induce multisystem manifestations and with its increasing and widespread prevalence [4952], this mechanism of disease is the preferred explanation of the authors for gluten-induced neuropsychiatric disease. As patients with SRI typically have multiple triggering agents, most commonly including gluten, casein, and sugar, this causative explanation would also address the uncertainty about NCGS that was highlighted in an editorial by Vanga and Leffler in Gastroenterology [53]. This mechanism also explains the apparently inexplicable onset of gluten sensitivity in patients who were previously well and fully tolerant of gluten and accounts for the reversal of gluten sensitivity in some patients who are successful in eliminating their toxicant burden [36].


5. Concluding Thoughts

There are many theories and hypotheses as to the origins of recurrent hallucinations including genetic illness, metaphysical attribution, and neurochemical disruption. The profound impact of such neuropsychiatric dysregulation on the lives of those afflicted is evident. Concomitant with this reality is escalating evidence about sensitivity-related disorders including intolerance and multimorbidity associated with gluten exposure. The widespread prevalence of gluten in the typical North American diet and the escalating numbers of published case reports linking gluten exposure with a myriad of manifestations raise awareness of a potential modifiable lifestyle determinant that may have a substantial impact on some individuals with neuropsychiatric and other health problems.

The individual in the presented case demonstrates a clear sensitivity to gluten with remission of longstanding hallucinations with gluten elimination and relapsing symptoms upon reintroduction of dietary gluten. The scientific literature contains numerous case reports where unexplained symptoms are significantly improved and, at times, completely resolved when similar dietary changes are made. Therefore, when clinicians are faced with physical symptoms that have not been otherwise explained, celiac testing may be warranted. If this is found to be negative, the possibility of NCGS and SRI ought to be considered. Although NCGS cannot be definitively diagnosed at this time based on laboratory investigations, a trial of gluten elimination should be incorporated as part of the clinical assessment and potential management.


Key Points

  1. Gluten ingestion in gluten sensitive individuals can lead to a variety of clinical presentations including psychiatric, neurological, gynecological, and cardiac symptoms.
  2. Dietary elimination of gluten may lead to complete symptom resolution.
  3. Health practitioners are advised to consider gluten elimination in patients with otherwise unexplained symptoms.
  4. Nonceliac gluten sensitivity may be a part of a constellation of symptoms resulting from a toxicant induced loss of tolerance (TILT).


Conflict of Interests

The authors declare that there is no conflict of interests. No funding has been received for any part of this work.

Authors' Contribution

Stephen J. Genuis and Rebecca A. Lobo have contributed equally to the preparation of this paper.


References
1. Hadjivassiliou M,Gibson A,Davies-Jones GA,Lobo AJ,Stephenson TJ,Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness?The LancetYear: 199634789983693712-s2.0-0030027634
2. Hadjivassiliou M,Sanders DS,Grünewald RA,Woodroofe N,Boscolo S,Aeschlimann D. Gluten sensitivity: from gut to brainThe Lancet NeurologyYear: 2010933183302-s2.0-76449102440
3. Burk K,Bösch S,Müller CA,et al. Sporadic cerebellar ataxia associated with gluten sensitivityBrainYear: 20011245101310192-s2.0-034252769811335703
4. Dickerson F,Stallings C,Origoni A,et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophreniaBiological PsychiatryYear: 20106811001042-s2.0-7795361087420471632
5. Dickerson F,Stallings C,Origoni A,Vaughan C,Khushalani S,Yolken R. Markers of gluten sensitivity in acute mania: a longitudinal studyPsychiatry ResearchYear: 2012196168712-s2.0-8486062586522386570
6. Rostami K,Hogg-Kollars S. A patient's journey. Non-coeliac gluten sensitivityBritish Medical JournalYear: 2012345e7982
7. Morant A. Psychosis and silent celiac disease in a down syndrome adolescent: a case reportCase Reports in PediatricsYear: 201120113 pages970143
8. Serratrice J,Disdier P,Kaladjian A,et al. Psychosis revealing a silent celiac disease in a young women with trisomy 21Presse MedicaleYear: 20023133155115532-s2.0-0037069081
9. Singh MM,Kay SR. Wheat gluten as a pathogenic factor in schizophreniaScienceYear: 197619142254014022-s2.0-00172865351246624
10. de Santis A,Addolorato G,Romito A,et al. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free dietJournal of Internal MedicineYear: 199724254214232-s2.0-00308598619408073
11. Hadjivassiliou M,Kandler RH,Chattopadhyay AK,et al. Dietary treatment of gluten neuropathyMuscle and NerveYear: 20063467627662-s2.0-3384534469317013890
12. Canales P,Mery VP,Larrondo FJ,Bravo FL,Godoy J. Epilepsy and celiac disease: favorable outcome with a gluten-free diet in a patient refractory to antiepileptic drugsNeurologistYear: 20061263183212-s2.0-3375135671417122729
13. Genuis SJ,Bouchard TP. Celiac disease presenting as autismJournal of Child NeurologyYear: 20102511141192-s2.0-7564912075819564647
14. Goel NK,McBane RD,Kamath PS. Cardiomyopathy associated with celiac diseaseMayo Clinic ProceedingsYear: 20058056746762-s2.0-1824436659915887437
15. Rajput R,Chatterjee S. Primary infertility as a rare presentation of celiac diseaseFertility and SterilityYear: 20109472771.e52771.e72-s2.0-7865020945920537625
16. Hyrailles V,Desprez D,Beauerère L,et al. Uveitis complicating celiac disease and cured by gluten-free dietGastroenterologie Clinique et BiologiqueYear: 19951955435442-s2.0-00293004267590010
17. Pereira CC,Corrêa PHS,Halpern A. Case report: recently diagnosed celiac disease as aggravating factor of osteoporosis in old womanArquivos Brasileiros de Endocrinologia e MetabologiaYear: 2006506112711322-s2.0-3384633648317221122
18. Aziz I,Sanders DS. Emerging concepts: from coeliac disease to non-coeliac gluten sensitivityThe Proceedings of the Nutrition SocietyYear: 20127157658022954208
19. Carroccio A,Mansueto P,Iacono G,et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entityThe American Journal of GastroenterologyYear: 20121071898190622825366
20. Loft DE,Nwokolo CU,Ciclitira PJ. The diagnosis of gluten sensitivity and coeliac diseas—the two are not mutually inclusiveEuropean Journal of Gastroenterology and HepatologyYear: 199810119119132-s2.0-00317730549872611
21. Brostoff J,Gamlin L. Food Allergies and Food InTolerance: The Complete Guide to Their Identification and TreatmentYear: 2000Rochester, NY, USAInner Traditions International
22. Biesiekierski JR,Newnham ED,Irving PM,et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trialThe American Journal of GastroenterologyYear: 201110635085142-s2.0-7995236219421224837
23. Sapone A,Bai JC,Ciacci C,et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classificationBMC MedicineYear: 201210, article 132-s2.0-84856578917
24. EnterolabSpecialized Laboratory Testing for Optimal Intestinal and Overall Health 2013, https://www.enterolab.com/Default.aspx.
25. Kappler M,Krauss-Etschmann S,Diehl V,Zeilhofer H,Koletzko S. Detection of secretory IgA antibodies against gliadin and human tissue transglutaminase in stool to screen for coeliac disease in children: validation studyBritish Medical JournalYear: 200633275352132142-s2.0-3164443697116377644
26. Brottveit M,Vandvik PO,Wojniusz S,Lovik A,Lundin KE,Boye B. Absence of somatization in non-coeliac gluten sensitivityScandinavian Journal of GastroenterologyYear: 20124777077722519894
27. British Medical Journal Poll Archive. Polls in 2012, http://www.bmj.com/about-bmj/poll-archive.
28. Aziz I,Hadjivassiliou M,Sanders DS. Does gluten sensitivity in the absence of coeliac disease exist?British Medical JournalYear: 2012345e7907
29. Biesiekierski JR,Peters SL,Newnham ED,Rosella O,Muir JG,Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydratesGastroenterologyYear: 2013145232032823648697
30. Mascord I,Freed D,Durrant B. Antibodies to foodstuffs in schizophreniaBritish Medical JournalYear: 197816123p. 13512-s2.0-0018273392
31. Kinnell HG,Kirkwood E,Lewis C. Food antibodies in schizophreniaPsychological MedicineYear: 198212185892-s2.0-00200818387079432
32. Ashkenazi A,Krasilowsky D,Levin S. Immunologic reaction of psychotic patients to fractions of glutenThe American Journal of PsychiatryYear: 197913610130613092-s2.0-0018728821384809
33. Reichelt KL,Landmark J. Specific IgA antibody increases in schizophreniaBiological PsychiatryYear: 19953764104132-s2.0-00289481087772650
34. Wilke I,Arolt V,Rothermundt M,Weitzsch C,Hornberg M,Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patientsEuropean Archives of Psychiatry and Clinical NeuroscienceYear: 199624652792842-s2.0-00299981928863007
35. Wei J,Hemmings GP. Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophreniaMedical HypothesesYear: 20056435475522-s2.0-1114424933315617864
36. Genuis SJ. Sensitivity-related illness: the escalating pandemic of allergy, food intolerance and chemical sensitivityScience of the Total EnvironmentYear: 201040824604760612-s2.0-7795810772720920818
37. Miller CS. Toxicant-induced loss of tolerance—an emerging theory of disease?Environmental Health PerspectivesYear: 199710524454532-s2.0-00309978869167978
38. Ashford N,Miller C. Chemical Exposures: Low Levels and High StakesYear: 19982nd editionNew York, NY, USAJohn Wiley and Sons
39. Genuis SJ,Siy AK. Nutritional supplementation and dietary restriction in the resolution of enthesitis-related arthritisJRSM Short ReportsYear: 201124p. 32
40. Pall ML. Ballantyne B,Marrs TC,Syversen TMultiple chemical sensitivity: toxicological questions and mechanismsGeneral and Applied ToxicologyYear: 20093rd editionchapter 20London, UKJohn Wiley and Sons
41. Pall ML. Explaining “Unexplained Illness”: Disease Paradigm for Chronic Fatigue Syndrome, Multiple Chemical Sensitivity, Fibromyalgia, Post-Traumatic Stress Disorder, Gulf War Syndrome and OthersYear: 2007New York, NY, USAHarrington Park Press
42. Genuis SJ. Chemical sensitivity: pathophysiology or pathopsychology?Clinical TherapeuticsYear: 20133557257723642291
43. NHANES4th National Report on Exposure to Environmental Chemical Exposures 2012, http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf.
44. Genuis SJ. The chemical erosion of human health: adverse environmental exposure and in-utero pollution—determinants of congenital disorders and chronic diseaseJournal of Perinatal MedicineYear: 20063431851952-s2.0-3364577391416602837
45. World Health OrganizationSate of the Science of Endocrine Disrupting Chemicals 2012: Summary for Decision-Makers United Nations Environment Programme and the World Health Organization, 2013.
46. Dantoft T,Elberling J,Brix S,Szecsi P,Vesterhauge S,Skovbjerg S. An elevated pro-inflammatory cytokine profile in un-exposed individuals with multiple chemical sensitivityPsychoneuroendocrinologyYear: 20144014015024485486
47. de Luca C,Scordo MG,Cesareo E,et al. Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymesToxicology and Applied PharmacologyYear: 201024832852922-s2.0-7795351191120430047
48. Genuis SJ. The pandemic of idiopathic multimorbidity Canadian Family Physician. In press.
49. Joffres MR,Williams T,Sabo B,Fox RA. Environmental sensitivities: prevalence of major symptoms in a referral center: the Nova Scotia environmental sensitivities research center studyEnvironmental Health PerspectivesYear: 200110921611652-s2.0-003506043511266327
50. Hausteiner C,Bornschein S,Hansen J,Zilker T,Förstl H. Self-reported chemical sensitivity in Germany: a population-based surveyInternational Journal of Hygiene and Environmental HealthYear: 200520842712782-s2.0-2044450572116078641
51. Berg ND,Linneberg A,Dirksen A,Elberling J. Prevalence of self-reported symptoms and consequences related to inhalation of airborne chemicals in a Danish general populationInternational Archives of Occupational and Environmental HealthYear: 20088178818872-s2.0-4254908641218058120
52. Miller CS,Ashford NA. Spengler JD,Samet JM,McCarthy JFMultiple chemical intolerance and indoor air qualityIndoor Air Quality HandbookYear: 2000chapter 27New York, NY, USAMacGraw-Hill
53. Vanga R,Leffler DA. Gluten sensitivity: not celiac and not certainGastroenterologyYear: 201314527627923806541

Article Categories:
  • Review Article


Previous Document:  The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with co...
Next Document:  An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in H...